1. Home
  2. SLNO vs FELE Comparison

SLNO vs FELE Comparison

Compare SLNO & FELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • FELE
  • Stock Information
  • Founded
  • SLNO 1999
  • FELE 1944
  • Country
  • SLNO United States
  • FELE United States
  • Employees
  • SLNO N/A
  • FELE N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FELE Metal Fabrications
  • Sector
  • SLNO Health Care
  • FELE Consumer Discretionary
  • Exchange
  • SLNO Nasdaq
  • FELE Nasdaq
  • Market Cap
  • SLNO 3.7B
  • FELE 4.4B
  • IPO Year
  • SLNO 2014
  • FELE N/A
  • Fundamental
  • Price
  • SLNO $48.65
  • FELE $90.66
  • Analyst Decision
  • SLNO Strong Buy
  • FELE Hold
  • Analyst Count
  • SLNO 10
  • FELE 1
  • Target Price
  • SLNO $110.90
  • FELE $107.00
  • AVG Volume (30 Days)
  • SLNO 2.3M
  • FELE 242.9K
  • Earning Date
  • SLNO 11-04-2025
  • FELE 10-28-2025
  • Dividend Yield
  • SLNO N/A
  • FELE 1.15%
  • EPS Growth
  • SLNO N/A
  • FELE N/A
  • EPS
  • SLNO N/A
  • FELE 3.07
  • Revenue
  • SLNO $98,675,000.00
  • FELE $2,110,140,000.00
  • Revenue This Year
  • SLNO N/A
  • FELE $7.80
  • Revenue Next Year
  • SLNO $181.30
  • FELE $4.77
  • P/E Ratio
  • SLNO N/A
  • FELE $30.00
  • Revenue Growth
  • SLNO N/A
  • FELE 5.06
  • 52 Week Low
  • SLNO $41.50
  • FELE $78.87
  • 52 Week High
  • SLNO $90.32
  • FELE $111.94
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 38.14
  • FELE 33.71
  • Support Level
  • SLNO $46.82
  • FELE $93.69
  • Resistance Level
  • SLNO $50.04
  • FELE $95.70
  • Average True Range (ATR)
  • SLNO 3.65
  • FELE 2.05
  • MACD
  • SLNO -0.83
  • FELE -0.45
  • Stochastic Oscillator
  • SLNO 22.23
  • FELE 14.97

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About FELE Franklin Electric Co. Inc.

Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.

Share on Social Networks: